To determine the in-vitro susceptibilities of delafloxacin and the comparator quinolones, the researchers tested clinical isolates from patients with community-acquired pneumonia and lower respiratory tract infections at 67 US-based medical centers that participated in the SENTRY Surveillance Program.
In this podcast, Thomas M. File, Jr, MD, MSc, MACP, talks about his session at CHEST 2021, during which he discussed the results of the LEAP 1 and 2 trials that evaluated the efficacy and safety of lefamulin for treating community-acquired pneumonia.
The study included 637 patients initiated on the pathway at seven SSM Health Wisconsin hospitals between September 1, 2020, and June 30, 2021.
In this podcast, Christian Sandrock, MD, MPH, talks about the burden of community-acquired bacterial pneumonia (CABP) in the United States, including the financial burden, the burden on hospitals, and readmission rates.
For Pediatric CAP, Lung Point-of-Care Ultrasonography May Be a Better Diagnostic Tool Than Chest Radiography
Children in whom WHO’s definition of severe pneumonia was met were enrolled in the study at a teaching hospital in Lusaka, Zambia, and received chest radiography as well as lung point-of-care ultrasonography imaging.
In this podcast, Frank LoVecchio, MD, speaks about the unmet needs in the treatment of community-acquired bacterial pneumonia, and potential alternatives to the standard treatment regimen. This podcast is part 3 of a 3-part series on the unmet needs of treatment for CABP.
Grant Waterer, MBBS, PhD, MBA, on the Latest ATS Guidelines on the Diagnosis and Treatment of Adults With CAP
In this Q&A, Grant Waterer, MBBS, PhD, MBA, answers our questions on the updates to the recommendations regarding the diagnosis of adults with community-acquired pneumonia, including consideration for inpatient vs outpatient care and whether the strain of bacteria that causes CAP affects treatment choice.
In this podcast, Frank LoVecchio, MD, discusses how treatment of community-acquired bacterial pneumonia is managed in the outpatient setting, and the challenges that come with outpatient management of these patients. This podcast is part 2 of a 3-part series on unmet needs in treatment of CABP.
Patients with either bronchitis or pneumonia may present with similar symptoms. But how do you discern between the two conditions? Answer this pop quiz question to test your knowledge on the main clinical difference between bronchitis and pneumonia.
In this podcast, Frank LoVecchio, MD, discusses typical and atypical presentations of community-acquired bacterial pneumonia (CABP), as well as important considerations for health care providers when determining the site of care for these patients. This podcast is part 1 of a 3-part series on unmet needs in treatment of CABP.